Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($0.28), $0.75 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $413.5 thousand versus the consensus estimate of $190 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.